Scarica l'app Stockscreener
1.21
1.63%
-0.02
Dopo l'orario di chiusura:
1.21
Inmune Bio Inc Borsa (INMB) Ultime notizie
INMune Bio, Inc. (NASDAQ:INMB) Q4 2025 earnings call transcript - MSN
Support Test: Whats the RSI of INmune Bio Inc stockWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn
INMB.O PE Ratio & Valuation, Is INMB.O Overvalued - Intellectia AI
INmune Bio (INMB) price target increased by 33.33% to 7.14 - MSN
INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript - Insider Monkey
INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely - Yahoo Finance
S P Trends: Whats the profit margin of INmune Bio IncWeekly Trade Report & Weekly Stock Performance Updates - baoquankhu1.vn
INmune Bio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | INmune Bio(INMB.US) Q4 2025 Earnings Conference - Moomoo
Inmune Bio Inc Stock: Recent 2025 Results Highlight Late-Stage Pipeline Progress Amid Cash Runway to - AD HOC NEWS
INmune Bio reports $45.9M loss, plans UK regulatory filing By Investing.com - Investing.com South Africa
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
INmune Bio Q4 2025 Earnings Call Transcript - marketbeat.com
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategi - GuruFocus
INmune Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: INmune Bio highlights CORDStrom progress in Q4 2025 - Investing.com Canada
INmune Bio | 10-K: FY2025 Annual Report - Moomoo
INMB: CORDStrom nears regulatory filings as cash runway extends to Q1 2027 after $27.5M raised - TradingView
Pipeline reset at INmune Bio (NASDAQ: INMB) after CORDStrom gains and XPro setback - Stock Titan
INmune Bio reports $45.9M loss, plans UK regulatory filing - Investing.com UK
INmune Bio Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Short Squeeze: Will INmune Bio Inc outperform tech stocksTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn
INMune Bio FY 2025 earnings preview - MSN
INmune Bio Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
INmune Bio Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView
INMB Technical Analysis | Trend, Signals & Chart Patterns | INMUNE BIO INC (NASDAQ:INMB) - ChartMill
INmune Bio (INMB.US) will release its earnings report after the market close on March 30. - Moomoo
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th. - The Manila Times
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on ... - Bluefield Daily Telegraph
INmune Bio will discuss 2025 results and corporate update March 30 - stocktitan.net
Market Moves: Whats the RSI of INmune Bio Inc stock2026 Buyback Activity & Low Drawdown Investment Ideas - baoquankhu1.vn
If You Invested $1,000 in Inmune Bio Inc (INMB) - Stock Titan
Block Trades: How does INmune Bio Inc compare to its peersMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn
INMB PE Ratio & Valuation, Is INMB Overvalued - Intellectia AI
INMB Showcases Advancements in Alzheimer's Treatment at AD/PD 20 - GuruFocus
INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s - TipRanks
INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease - The Manila Times
Alzheimer’s trial gets plenary spotlight as blood markers guide treatment - Stock Titan
INMB stock rises pre-market – what did the FDA say about its Alzheimer’s trial? - MSN
Rally Mode: Whats the profit margin of INmune Bio IncTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Outlook: Is INmune Bio Inc stock undervalued right nowPortfolio Risk Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Setup Watch: How liquid is INmune Bio Inc stockTrade Entry Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Will INmune Bio Inc benefit from geopolitical trends2026 Momentum & Free Community Supported Trade Ideas - baoquankhu1.vn
INmune Bio Inc Stock (ISIN: US45764T1060) Faces Analyst Hold Consensus Amid $8 Price Target - AD HOC NEWS
INmune Bio Receives $8 Consensus Price Target from Analysts - National Today
INmune Bio (NASDAQ:INMB) Stock Rating Upgraded by Lucid Cap Mkts - Defense World
Lucid Capital Markets upgrades INmune Bio (INMB) - MSN
INMB Stock Receives Major Upgrade from Lucid Capital Markets | I - GuruFocus
Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy - Investing.com Australia
Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy By Investing.com - Investing.com India
INmune Bio, Inc. (NASDAQ:INMB) Given Average Recommendation of “Reduce” by Analysts - Defense World
INMB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sentiment Watch: Whats the RSI of INmune Bio Inc stockBreakout Watch & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Breakout Zone: Is INmune Bio Inc stock undervalued right nowMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Wrap: What is the earnings history of INmune Bio IncJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):